New treatments for refractory cutaneous T-cell lymphoma (CTCL).
| Abbreviations: EPOCH, etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone; IL, interleukin. |
| Alemtuzumab (Campath 1-H) |
| EPOCH chemotherapy |
| Autologous/allogeneic bone marrow transplantation |
| FK228 (depsipeptide) |
| Temozolamide |
| Intermediate dose IL-2 |
| IL-12 +/- low-dose IL-2 |
| 90Y anti-CD25 antibody |
| Anti-Tac-pseudomonas immunoconjugates |
| Abbreviations: EPOCH, etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone; IL, interleukin. |
| Alemtuzumab (Campath 1-H) |
| EPOCH chemotherapy |
| Autologous/allogeneic bone marrow transplantation |
| FK228 (depsipeptide) |
| Temozolamide |
| Intermediate dose IL-2 |
| IL-12 +/- low-dose IL-2 |
| 90Y anti-CD25 antibody |
| Anti-Tac-pseudomonas immunoconjugates |